Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated?
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In women with endometriosis, the lifetime risk of ovarian cancer is increased from 1.4% to about 1.9%. The risk of clear cell and endometrioid ovarian cancer is, respectively, tripled and doubled. Atypical endometriosis, observed in 1-3% of endometriomas excised in premenopausal women, is the intermediate precursor lesion linking typical endometriosis and clear cell/endometrioid tumors. Prolonged oral contraceptive use is associated with a major reduction in ovarian cancer risk among women with endometriosis. Surveillance ± progestogen treatment or surgery should be discussed in perimenopausal women with small, typical endometriomas. In most perimenopausal women with a history of endometriosis but without endometriomas, surveillance instead of risk-reducing bilateral salpingo-oophorectomy seems advisable. Risk-reducing salpingo-oophorectomy might benefit patients at particularly increased risk, but the evidence is inconclusive. Risk profiling models and decision aids may assist patients in their choice. Screening of the general perimenopausal population to detect asymptomatic endometriomas is unlikely to reduce disease-specific mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712 · cited 2×
“[31] Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K , Zeng T, et al.”
BackgroundJacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K., Amso, N. N., Apostolidou, S., Benjamin, E., Cruickshank, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01224-6 · Cited by 1,048
Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70404-1 · Cited by 939
Guerriero, S., Condous, G., van den Bosch, T., Valentin, L., Leone, F. P. G., Van Schoubroeck, D., Exacoustos, C., Installé, A. J. F., Martins, W. P., Abrao, M. S., et al. (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.15955 · Cited by 900
Self-citationParker, W. H., Broder, M. S., Chang, E., Feskanich, D., Farquhar, C., Liu, Z., Shoupe, D., Berek, J. S., Hankinson, S., & Manson, J. E. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181a11c64 · Cited by 640
Cancer-associated mutations in endometriosis without cancer
Anglesio, M. S., Papadopoulos, N., Ayhan, A., Nazeran, T. M., Noë, M., Horlings, H. M., Lum, A., Jones, S., Senz, J., Seckin, T., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614814 · Cited by 628
Sanchez, A. M., Viganò, P., Somigliana, E., Panina-Bordignon, P., Vercellini, P., & Candiani, M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt053 · Cited by 357
Self-citationKobayashi, H., Sumimoto, K., Moniwa, N., Imai, M., Takakura, K., Kuromaki, T., Morioka, E., Arisawa, K., & Terao, T. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00754.x · Cited by 305
Ogawa, S., Kaku, T., Amada, S., Kobayashi, H., Hirakawa, T., Ariyoshi, K., Kamura, T., & Nakano, H. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5765 · Cited by 279
Pinsky, P. F., Yu, K., Kramer, B. S., Black, A., Buys, S. S., Partridge, E., Gohagan, J., Berg, C. D., & Prorok, P. C. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.08.334 · Cited by 191
Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery
Rossing, M. A., Cushing-Haugen, K. L., Wicklund, K. G., Doherty, J. A., & Weiss, N. S. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9207-9 · Cited by 117 · cited 3×
“[8] Rossing MA, Cushing-Haugen KL, Wicklund KG, Doh erty JA, Weiss NS.”
BackgroundVERCELLINI, P., DE MATTEIS, S., SOMIGLIANA, E., BUGGIO, L., FRATTARUOLO, M. P., & FEDELE, L. (2013) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01470.x · Cited by 115
Self-citation‘Blood On The Tracks’ from corpora lutea to endometriomas*
Vercellini, P., Somigliana, E., Vigano, P., Abbiati, A., Barbara, G., & Fedele, L. (2009) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.02055.x · Cited by 114 · cited 2×
“This effect seems to be due to ovulation i nhibition, as endometriomas have been 453 demonstrated to derive from corpora lutea [72].”
BackgroundSelf-citationHormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer
Melin, A., Lundholm, C., Malki, N., Swahn, M., Sparèn, P., & Bergqvist, A. (2013) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12123 · Cited by 75 · cited 3×
“[9] Melin AS, Lundholm C, Malki N, Swahn ML, Sparèn P, Bergqvist A.”
BackgroundMethodDevelopment of ovarian cancer after excision of endometrioma
Haraguchi, H., Koga, K., Takamura, M., Makabe, T., Sue, F., Miyashita, M., Urata, Y., Izumi, G., Harada, M., Hirata, T., et al. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.07.1077 · Cited by 36 · cited 2×
“[66] Haraguchi H, Koka K, Takamura M, Makabe T, Sue F, Miyashita M, et al.”
BackgroundManagement of endometriosis: Toward value-based, cost-effective, affordable care
Vercellini, P., Facchin, F., Buggio, L., Barbara, G., Berlanda, N., Frattaruolo, M. P., & Somigliana, E. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.011 · Cited by 36
Self-citationTaniguchi, F., Harada, T., Kobayashi, H., Hayashi, K., Momoeda, M., & Terakawa, N. (2014) · Gynecologic and Obstetric Investigation · doi:10.1159/000357819 · Cited by 31
Vercellini, P., Frattaruolo, M. P., & Buggio, L. (2018) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2018.1411803 · Cited by 24 · cited 2×
“These factors augment the overall burden of treatment, including out420 of-pocket costs, and may unfavorably impact on heal t -related quality of life [67].”
BackgroundSelf-citation
Cited by
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Endometriosis and cancer: a systematic review and meta-analysis
Kvaskoff, M., Mahamat-Saleh, Y., Farland, L. V., Shigesi, N., Terry, K. L., Harris, H. R., Roman, H., Becker, C. M., As-Sanie, S., Zondervan, K. T., et al. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa045 · Cited by 303
The Endometriotic Tumor Microenvironment in Ovarian Cancer
Wendel, J. R. H., Wang, X., & Hawkins, S. M. (2018) · Cancers · doi:10.3390/cancers10080261 · Cited by 51
“Endometriosis is a known risk factor for ovarian cancer [41].”
BackgroundJiang, N., Xie, H., Lin, J., Wang, Y., & Yin, Y. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/3123310 · Cited by 19
“; sometimes, it also occurs in the umbilicus, bladder, kidney, ureter, lung, pleura, breast, and even arms and thighs [4].”
Background
Metadata
- Authors
- Vercellini, P., Viganò, P., Buggio, L., Makieva, S., Scarfone, G., Cribiù, F. M., Parazzini, F., & Somigliana, E.
- Venue
- Best Practice & Research Clinical Obstetrics & Gynaecology
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 51
- Pages
- 151-168
- ISSN
- 1521-6934 (ISSN-L)
- OpenAlex
- W2794270388
- Cited by
- 79
- References
- 18
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.